Seventy-five percent of the net proceeds raised by the Komen 3-Day help Susan G. Komen® support the global research program and other mission objectives, while the remaining 25 percent helps Affiliates support local programs including medical assistance, patient navigation and provider education, for example.
Fulfilling the Promise
In 1980, Nancy G. Brinker promised her dying sister, Susan, that she would do everything in her power to end breast cancer forever. In 1982, that promise became the Susan G. Komen® organization and the beginning of a global movement. What was started with $200 and a shoebox full of potential donor names has now grown into the world’s largest nonprofit source of funding for the fight against breast cancer. To date, Komen has funded more than $889 million in research and provided $1.95 billion in funding to screening, education, treatment and psychosocial support programs serving millions of people in more than 30 countries worldwide. And we won’t stop until our promise is fulfilled.
Progress in the Fight Against Breast Cancer
Since 1982, Komen has contributed to many of the advances made in the fight against breast cancer. We’ve transformed how the world treats and talks about this disease and have helped turn millions of breast cancer patients into breast cancer survivors. We are proud of our contribution to some very real victories:
- More early detection and effective treatment. Currently, about 66 percent of women 40 and older receive regular mammograms, the best screening test to find breast cancer early. Since 1990, early detection and effective treatment have resulted in a 34 percent decline in breast cancer mortality in the U.S.
- More hope. In 1980, the five-year relative survival rate for women diagnosed with early stage breast cancer was about 74 percent. Today, it’s 99 percent.
- More research. The federal government now devotes more than $750 million each year to breast cancer research, treatment and prevention, compared to $30 million in 1982.
- More survivors. Currently, there are more than 3 million breast cancer survivors in the U.S.
Your Fundraising at Work:
- On any given day, more than 1,000 women receive a free screening mammogram made possible by a Komen community grant.
- Komen research investments have led to new technologies like Lymphoseek®, a new imaging agent that more accurately identifies cancer-containing lymph nodes.
- Since 1990, Komen investments in early detection and effective treatments have helped drive down breast cancer mortality rates in the U.S. by 34 percent.
- Last year, Komen community grants provided financial and social support for more than 50,000 families impacted by breast cancer.
- Komen Affiliates annually fund nearly 1,300 community organizations to provide education, screening, diagnostic and emergency financial support for those facing breast cancer.
- Komen has reached nearly six million people in their own communities with educational materials to empower them to make informed breast care decisions for themselves and their loved ones.
- Komen has created a Tissue Bank that is the only place where researchers all over the world can access healthy breast tissue needed to study the causes and prevention of breast cancer.
Komen’s Mission and Approach to Funding
Komen Funding and Planned Parenthood
Komen’s Statement on Mammography
Komen Affiliate Events
Links and Information for Families, Patients and Advocates
3-Day Impact Since 2003
Your Funds at Work
Questions and Answers
Komen Mission Webinars
Komen's mission, vision and Bold Goal
Breast Cancer Fact Sheet